COMMUNIQUÉS West-GlobeNewswire

Retrophin to Present at the 8th Annual SVB Leerink Global Healthcare Conference
14/02/2019
SAN DIEGO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive officer, will present at the 8 th Annual SVB Leerink Global Healthcare Conference in New [...]
Paratek Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference
14/02/2019
BOSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
Guardant Health to Present at the 8th Annual Leerink Partners Global Healthcare Conference
14/02/2019
REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]
Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update
14/02/2019
Net cash used in operating and investing activities was $22.5 million in the fourth quarter and $30.0 million for the full year 2018; quarter-end cash and restricted cash position of $431.7 million provides funding to [...]
Ohr Pharmaceutical Reports Financial Results for the Fiscal First Quarter of 2019
14/02/2019
Stockholder vote on the proposed merger with NeuBase Therapeutics anticipated in the second calendar quarter of 2019 NEW YORK, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) (the “Company” or [...]
CytomX Therapeutics to Announce Full-Year 2018 Financial Results and Host Webcast Conference Call
14/02/2019
-Teleconference Scheduled for February 27, 2019, at 5:00 p.m. ET- -Company to Host Research and Development Day on February 26, 2019 in New York City- SOUTH SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- [...]
Lysogene and Sarepta Therapeutics Announce Dosing of the First Patient in AAVance, a Phase 2/3 Clinical Trial Investigating LYS-SAF302, a Gene Therapy for the Treatment of MPS IIIA (Sanfilippo Syndrome Type A)
14/02/2019
-- Trial to assess efficacy on neurodevelopmental status of MPS IIIA patients -- CAMBRIDGE, Mass. and PARIS, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a pioneering biopharmaceutical company [...]
Achaogen Announces Proposed Public Offering of Common Stock
14/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]
Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Azacitidine in Blood Advances
14/02/2019
Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Azacitidine in the Frontline Treatment of Older AML Patients Unfit for Intensive Chemotherapy, in Blood Advances Lugano, [...]
Physeon’s Veinplicity Device Featured on ABC Affiliate KSTP Channel 5
14/02/2019
“VIVA” Trial Enrolling at Mayo Clinic SCHAFFHAUSEN, Switzerland, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Physeon GmbH, (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today [...]
Rafina Innovations Begins Development on a Prototype for Sleep Apnoea
14/02/2019
GLASGOW, SCOTLAND, Feb. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc. ("the Company" (OTCQB: VICA)) is delighted to announce that it recently commenced development on a prototype for sleep [...]
PLx Pharma Inc. Announces Adjournment of Special Meeting of Stockholders
14/02/2019
HOUSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“ PLx ” or the “ Company ”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore™ [...]
PSIQ Enters the Projected $ 60 Billion Global Kosher Food Market
14/02/2019
SUNRISE, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Solutions, Inc. (OTC Pink: PSIQ), through its subsidiary Elite Products International, Inc., announces it has granted distribution rights to IT Distributions, LLC. to [...]
Coherus BioSciences to Report Fourth Quarter and Full Year 2018 Financial Results on February 28th
14/02/2019
REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that its fourth quarter and full year 2018 financial results will be released after market close on [...]
Lundbeck and Otsuka report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder
14/02/2019
The efficacy of brexpiprazole for the acute treatment of manic episodes, with or without mixed features, in subjects with bipolar I disorder was investigated in two three-week, double-blind, placebo-controlled trials [...]
Umbrellux DAO Provides Solution to Americans Who Thought They Had an Allergy, but Really Suffer from Histamine Intolerance
14/02/2019
ANN ARBOR, Mich., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Only 10 percent of Americans have food allergies, but according to a new study in JAMA Network Open , almost double the number believe they do. Could the other half [...]
Cannabis Beverages Coming Soon! Which of These 4 Brands Will Be on Store Shelves First?
14/02/2019
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Mugglehead says cannabis beverages are going to be the talk of 2019. With Canada set to legalize edibles and the U.S. recently passing the Farm Bill, both [...]
Radius Health to Announce Fourth Quarter and Full Year 2018 Financial Results, Host Conference Call and Live Webcast on Thursday, February 28, 2019
14/02/2019
WALTHAM, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its fourth quarter and full year 2018 financial results on Thursday, February 28, 2019. The Company [...]
NovuHealth Data Showcases the Value of Annual Wellness Visits for Medicare and Medicaid Members
14/02/2019
Data Confirm That AWVs Serve as an Important Gateway, as Those Who Receive One Are Up To 10 Times More Likely to Complete Other High-Value Healthcare Activities MINNEAPOLIS, Feb. 14, 2019 (GLOBE NEWSWIRE) -- NovuHealth [...]

Pages